Showing results (91-100 of 463) with videos related to
Sort By:
Pageof 47
European Journal of Neurology|February 19, 2009
Ethnicity a risk factor? The relation between ethnicity and large- and small-vessel disease in White people, Black people, and Asians within a hospital-based populationJ Wolma, P J Nederkoorn, A Goossens, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 1997
Machado-Joseph disease presenting as severe asymmetric proximal neuropathyI N van Schaik, G J Jöbsis, M Vermeulen, et al.Anesthesia and Analgesia|September 14, 2016
Implication of UGT2B15 Genotype Polymorphism on Postoperative Anxiety Levels in Patients Receiving Lorazepam PremedicationHerjan Mijderwijk, Markus Klimek, Stefan van Beek, et al.Journal of Neuroimmunology|August 12, 2023
Serum B-cell activating factor is not a potential biomarker for disease activity in chronic inflammatory demyelinating polyneuropathyMilou R Michael, Luuk Wieske, Marleen J Koel-Simmelink, et al.Neurology|October 15, 2008
Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1aA J Videler, J P van Dijk, A Beelen, et al.Journal of the Peripheral Nervous System : JPNS|May 16, 2019
Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathyIlse M Lucke, Luuk Wieske, Anneke J van der Kooi, et al.The Cochrane Database of Systematic Reviews|January 14, 2017
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviewsAnne Louise Oaklander, Michael Pt Lunn, Richard Ac Hughes, et al.Journal of Clinical Medicine|December 11, 2022
The Predictive Power of the 14-51 Ng/L High Sensitive Troponin T (hsTnT) Values for Predicting Cardiac Revascularization in a Clinical SettingFrank W De Jongh, Sjaak Pouwels, Marjolein C De Jongh, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 25, 2018
Confirmation practice in pharmacogenetic testing; how good is good enough?Carin A T C Lunenburg, Henk-Jan Guchelaar, Ron H N van Schaik, et al.Pharmacology Research & Perspectives|July 12, 2018
Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of CYP2D6, CYP2B6, and CYP3A4 genotypePernilla Haage, Robert Kronstrand, Martin Josefsson, et al.Pageof 47